Key result
Resumption of anticoagulants at a median of 4 days after intracerebral hemorrhage was associated with a low risk of recurrent hemorrhage, with no recurrences observed in patients who resumed direct oral anticoagulants.
Why the study?
Does the early resumption of anticoagulants (around 4 days) after intracerebral hemorrhage affect the risk of recurrent bleeding and ischemic stroke?
Observational (n=37)
No
Does the early resumption of anticoagulants (around 4 days) after intracerebral hemorrhage affect the risk of recurrent bleeding and ischemic stroke?
Resuming anticoagulants, particularly DOACs, around 4 days after intracerebral hemorrhage appears to have a low risk of rebleeding when accompanied by strict risk management.
May inform early resumption decisions after ICH; leaves open confirmation in randomized trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hasegawa et al. (2016) conducted an observational in Intracerebral hemorrhage (n=37). Resumption of anticoagulants vs. No resumption was evaluated on Recurrent intracerebral hemorrhage. Resumption of anticoagulants at a median of 4 days after intracerebral hemorrhage was associated with a low risk of recurrent hemorrhage, with no recurrences observed in patients who resumed direct oral anticoagulants.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: